Huizhong X. Li

209 Tongshan Road
Xuzhou, 221004, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications

VISTA neutralization by immunization reprograms immunosuppression and augments vaccine efficacy in renal carcinoma.

VISTA neutralization by immunization reprograms immunosuppression and augments vaccine efficacy in renal carcinoma.

Journal: Journal for immunotherapy of cancer
Published: April 20, 2026

Single- and dual-target CAR-T cells targeting HBsAg and GPC3 to balance safety and antitumor efficacy in HBV-positive hepatocellular carcinoma.

Single- and dual-target CAR-T cells targeting HBsAg and GPC3 to balance safety and antitumor efficacy in HBV-positive hepatocellular carcinoma.

Journal: iScience
Published: January 30, 2026

BCMA/CD19 CAR T cell therapy for refractory myasthenia gravis: Proteomic signatures and single-cell transcriptomics of disease flares.

BCMA/CD19 CAR T cell therapy for refractory myasthenia gravis: Proteomic signatures and single-cell transcriptomics of disease flares.

Journal: Science advances
Published: January 02, 2026

Tumor-Derived Exosomal Fatty Acids Reprogram Neutrophils to Drive Neutrophil Extracellular Traps Formation and Lung Cancer Progression.

Tumor-Derived Exosomal Fatty Acids Reprogram Neutrophils to Drive Neutrophil Extracellular Traps Formation and Lung Cancer Progression.

Journal: Research (Washington, D.C.)
Published: November 10, 2025

Anti-BCMA/CD19 CAR T cell therapy in patients with refractory generalized myasthenia gravis: a single-arm, phase 1 trial.

Anti-BCMA/CD19 CAR T cell therapy in patients with refractory generalized myasthenia gravis: a single-arm, phase 1 trial.

Journal: EClinicalMedicine
Published: August 06, 2025

Signaling intact membrane-bound IL-15 enables potent anti-tumor activity and safety of CAR-NK cells.

Signaling intact membrane-bound IL-15 enables potent anti-tumor activity and safety of CAR-NK cells.

Journal: Frontiers in immunology
Published: July 02, 2025

Clinicopathologic features with pulmonary and tracheal glomus tumor: report of 8 cases

Clinicopathologic features with pulmonary and tracheal glomus tumor: report of 8 cases

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]
Published: April 23, 2025

Corrigendum to "Ectopic expression of NKG7 enhances CAR-T function and improves the therapeutic efficacy in liquid and solid tumors" [Pharmacol. Res. 210 (2024) 107506].

Corrigendum to "Ectopic expression of NKG7 enhances CAR-T function and improves the therapeutic efficacy in liquid and solid tumors" [Pharmacol. Res. 210 (2024) 107506].

Journal: Pharmacological research
Published: February 23, 2025

Clinicopathological analysis of primary gastric oncocytic neuroendocrine tumors

Clinicopathological analysis of primary gastric oncocytic neuroendocrine tumors

Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology
Published: January 25, 2025

Gene armoring: A way to enhance CAR-T cell function.

Gene armoring: A way to enhance CAR-T cell function.

Journal: Pharmacological research
Published: January 16, 2025

Ectopic expression of NKG7 enhances CAR-T function and improves the therapeutic efficacy in liquid and solid tumors.

Ectopic expression of NKG7 enhances CAR-T function and improves the therapeutic efficacy in liquid and solid tumors.

Journal: Pharmacological research
Published: November 11, 2024

Preclinical assessment of the efficacy of B7-H3 CAR-T in renal cell carcinoma.

Preclinical assessment of the efficacy of B7-H3 CAR-T in renal cell carcinoma.

Journal: Molecular immunology
Published: October 09, 2024
Showing 1-12 of 71

Last Updated: 09/26/2026